FAST TRACK FACTS | MICRO-LEARNING
Disease-Specific Matrix Specificity Testing for PK and ADA Methods for Large Molecules
Click the image to view the video
Why does the ICH bioanalytical validation guideline require disease-specific matrix selectivity testing for biologics? In this short video, we’ll break down the science and significance behind this mandate for both PK and ADA assays.
Interested in diving deeper?
TRAINING VIDEO
An Introduction to Developing and Validating Ligand-Binding PK Assays for Biologics
0